MBD

MBD (Medical and Biological Devices Co., Ltd.) is a global leading company in 3D cell culture headquartered in Korea. Established in 2015, it aims to provide a drug efficacy and toxicity prediction platform based on the following three aspects: dimensional cell culture. The 3D cell chip (CellVitro) with a hydrogel-based columnar structure is a technology that can overcome the problems of conventional two-dimensional cell culture. It has been proven by pharmaceutical companies, hospitals, and research institutions to be an excellent technology. In addition, they are laying the foundation for improving cancer treatment by using patient-derived cancer cells to provide individuals with optimal anti-cancer drugs as part of personalized treatment.